Short- and long-term effects of T-cell modulating agents in experimental autoimmunity
Authors:
- Said HavarinasabSHSaid Havarinasab
- Per HultmanPHPer Hultman
- 1 March 2004
- journal article
- Published by Elsevier in Toxicology
- Vol. 196 (3) , 197-209
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Anti-Cytokine Therapy for Rheumatoid ArthritisAnnual Review of Medicine, 2000
- The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response—anin vivomodel of Th2-like activityClinical and Experimental Immunology, 1995
- Age Influences Recovery of Systemic and Mucosal Immune Responses Following Acute Depletion of CD4 T CellsClinical Immunology and Immunopathology, 1993
- Murine systemic autoimmune disease induced by mercuric chloride (HgCl2): Hg-specific helper T-cells react to antigen stored in macrophagesInternational Journal of Immunopharmacology, 1993
- Murine susceptibility to mercuryClinical Immunology and Immunopathology, 1992
- Anti‐CD4 Monoclonal Antibodies in Therapy: Creation of Nonclassical Tolerance in the AdultImmunological Reviews, 1992
- Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN ratClinical and Experimental Immunology, 1992
- In vivo depletion of CD4 T cells increases B cell sensitivity to polyclonal activation: The role of interferon-γClinical Immunology and Immunopathology, 1992
- Generation and Analysis of Interleukin-4 Deficient MiceScience, 1991
- Chronic in vivo depletion of CD4 T cells increases both serum IgM levels and the expressed frequency of anti-ssDNA precursors in both NZB and miceClinical Immunology and Immunopathology, 1990